当前位置: 首页 > 详情页

Can upper airway surgery for OSA protect against cardiovascular sequelae via effects on coagulation?

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [3]Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [4]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [5]Beijing Anzhen Hosp, 2 Anzhen Rd, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Obstructive sleep apnea (OSA) polysomnography blood coagulation upper airway surgery cardiovascular disease

摘要:
Conclusion: Upper airway surgery is associated with salutary effects on the blood coagulation characteristics of OSA patients, a benefit that may be protective against cardiac and cerebrovascular morbidity and mortality. Objective: Increased blood coagulation is an important factor linking OSA and cardiovascular complications. Surgery is an important method to treat OSA, but the effect of surgery on blood coagulation in OSA patients is unknown. Methods: the authors performed a prospective clinical trial of adult OSA patients who underwent surgery from 2012-2014. Preoperative and post-operative blood coagulation parameters and polysomnography (PSG) results were compared. Result: There were 61 subjects. The total rate of success in curing OSA was 11.5%. The rate of response after surgery was 40.8%. Overall, the Apnea-Hypopnea Index (AHI) improved after surgery (from 39.8 3 +/- 24.49 to 25.9 7 +/- 18.53, p<0.01). After surgery, serum platelet counts (PLT) decreased (from 242.5 +/- 52.6 to 230.9 +/- 40.7, p = 0.01), and Fibrinogen (FIB) levels declined (from 262.5 +/- 52.5 to 247.3 +/- 44.4, p = 0.02). Other blood coagulation parameters also improved: prothrombin time (PT) (from 10.6 2 +/- 0.62 to 10.8 6 +/- 0.70, p = 0.01), activated partial thromboplastin time (APTT) (from 26.9 8 +/- 4.94 to 27.7 8 +/- 3.02, p = 0.06), and Thrombin time (TT) (from 19.53 +/- 0.84 to 20.1 1 +/- 1.31, p<0.01).

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 耳鼻喉科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 耳鼻喉科学
JCR分区:
出版当年[2014]版:
Q3 OTORHINOLARYNGOLOGY
最新[2023]版:
Q3 OTORHINOLARYNGOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [5]Beijing Anzhen Hosp, 2 Anzhen Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院